- Home
- GNLX
GNLX
Genelux Corporation
as 10-29-2025 9:36am EST
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | WESTLAKE VILLAGE |
| Market Cap: | 128.0M | IPO Year: | 2023 |
| Target Price: | $17.40 | AVG Volume (30 days): | 226.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.86 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.99 - $8.27 | Next Earning Date: | 11-13-2025 |
| Revenue: | N/A | Revenue Growth: | -95.29% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Genelux Corporation News
GNLX Breaking Stock News: Dive into GNLX Ticker-Specific Updates for Smart Investing
PR Newswire
10 days ago
United Imaging Marks Five Years Since the Opening of its Global Showroom In North America with a Record Number of U.S. Customer Visits
NFL Highlights
10 days ago
Rapoport: Vikings won't make long-term QB decision until J.J. McCarthy is fully healthy
Moneywise
10 days ago
102-yr-old Houston woman thrives solo — wears high heels, jewelry, and shops on her own. How to make cash last past 100
Benzinga
10 days ago
Patagonia Founder Hated Being Called a Billionaire – So He Gave His Fortune Away
Simply Wall St.
10 days ago
CAE (TSE:CAE) shareholders have earned a 9.8% CAGR over the last five years
GOBankingRates
10 days ago
Real Estate Agents Predict Which Cities Will Be Cheaper To Rent Than Buy in 2026
AFP
10 days ago
Israel and Hamas accuse each other of breaching Gaza truce amid strikes, clashes
PR Newswire
10 days ago
Max Stock Limited releases an immediate report on holdings of interested parties and senior officers as of September 30, 2025
Compare GNLX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GNLX Genelux Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.